InspireMD Inc NSPR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
FDA Approves InspireMD's Application to Initiate Study of Neuro Protection System — Update
-
InspireMD Withdraws Guidance, Recalls CGuard Prime
-
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of InspireMD, Inc. (NASDAQ: NSPR)
-
InspireMD Stock Surges on FDA Approval for CGuard Stent
Trading Information
- Previous Close Price
- $0.71
- Day Range
- $0.67–0.72
- 52-Week Range
- $0.63–2.93
- Bid/Ask
- $0.72 / $0.74
- Shares Outstanding
- 46.84M
- Market Cap
- $33.72M
- Volume/Avg
- 159,321 / 318,830
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.82
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 127
- Website
- https://www.inspiremd.com
Valuation
|
Metric
|
NSPR
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.77 |
Price/Sales | 4.82 |
Price/Cash Flow | — |
Price/Earnings
NSPR
Financial Strength
|
Metric
|
NSPR
|
|---|---|
Quick Ratio | 4.70 |
Current Ratio | 5.15 |
Interest Coverage | — |
Quick Ratio
NSPR
Profitability
|
Metric
|
NSPR
|
|---|---|
Return on Assets (Normalized) | −72.05% |
Return on Equity (Normalized) | −94.14% |
Return on Invested Capital (Normalized) | −89.65% |
Return on Assets
NSPR
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|RMS@PM | LOCK|s%>Z | $164B | |||
| Stryker Corp
SYK
| LOCK|RGP&&%#M | LOCK|>> | $126B | |||
| Medtronic PLC
MDT
| LOCK|t!w#D!b | LOCK|?mJ^ | $107B | |||
| Boston Scientific Corp
BSX
| LOCK|qHM>l$ | LOCK|Nzy# | $67B | |||
| Edwards Lifesciences Corp
EW
| LOCK|#XWKg&G@ | LOCK|cp&$ | $53B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|pZ?g%S | LOCK|??b | $29B | |||
| DexCom Inc
DXCM
| LOCK|t#q<ns@ | LOCK|&sClq | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|&M | LOCK|!!Y | $27B | |||
| Steris PLC
STE
| LOCK|MT@yDkK | LOCK|l<?qj | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|>%>LWZgW | LOCK|>%z | $18B |
United States